Expert Perspectives on SGLT2 Inhibitors: Reviewing Their Role in Type 2 Diabetes, Heart Failure and Chronic Kidney Disease

Educational Activity

Faculty Listing


Richard E. Pratley, MD

Samuel E. Crockett Chair in Diabetes Research

Medical Director

AdventHealth Diabetes Institute

Senior Investigator and Diabetes Program Lead

AdventHealth Translational Research Institute

Adjunct Professor of Medicine

Johns Hopkins University School of Medicine


Faculty Disclosures


In accordance with the Food and Drug Administration, the speakers have disclosed that there is the potential for discussions concerning off-label uses of a commercial product/device during this educational activity.


Any person who may contribute to the content of this continuing educa­tion activity must disclose relevant relationships (and any known relation­ships of their spouse/partner) with commercial interests whose products or services are discussed in educational presentations. A commercial inter­est is defined as any entity producing, marketing, re-selling, or distribut­ing health care goods or services consumed by, or used on, patients. Relevant relationships include receiving from a commercial interest research grant, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.


Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with infor­mation that might be of potential importance to their evaluation of a presentation.


Richard E. Pratley, MD reports research grants and consulting and/or speakers fees from Hanmi Pharmaceutical Co, Janssen, MSD, Novo Nordisk, Pfizer Inc, Poxel SA, Sanofi, Scohia Pharma Inc, and Sun Pharmaceutical Industries. All honoraria are directed toward a non-profit organization supporting education and research.




Matthew Frese, MBA, General Manager of Med Learning Group, has nothing to disclose.

Christina Gallo, SVP, Educational Development for Med Learning Group, has nothing to disclose.

Debra Gordon, MS, Medical Director for Med Learning Group, owns stock in Merck and AbbVie.

Lauren Welch, MA, VP, Accreditation and Outcomes for Med Learning Group, has nothing to disclose.

Briana Hanson, MPH, Accreditation and Outcomes Coordinator for Med Learning Group, has nothing to disclose.

Ashley Whitehurst, Program Manager for Med Learning Group, has nothing to disclose.



Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.


During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

Powered by Oasis.